p53-Dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions

Laboratory Investigation

Volumn 85, Issue 4, 2005, Pages 502-511

  Gorgoulis, Vassilis G ^a   Pratsinis, Harris ^b   Zacharatos, Panayotis ^a   Demoliou, Catherine ^c   Sigala, Fragiska ^d   Asimacopoulos, Panayiotis J ^e   Papavassiliou, Athanasios G ^f   Kletsas, Dimitris ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Institute of Biology   (Greece)

^c CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^d St Josef Hospital   (Germany)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF PATRAS   (Greece)

Author keywords

Aging; Atherosclerosis; Fibroblasts; ICAM 1; p53; Smooth muscle cells

Indexed keywords

BETA GALACTOSIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN P53;

AGED; ARTICLE; ATHEROSCLEROSIS; CELL DIVISION; CHRONIC INFLAMMATION; CONTROLLED STUDY; FETUS; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; SMOOTH MUSCLE FIBER; SOMATIC CELL; VASCULAR SMOOTH MUSCLE;

ARTERIOSCLEROSIS; BASE SEQUENCE; CELL AGING; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 17144400369     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700241     Document Type: Article

References (49)

1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-636.
2. Campisi J. Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatr Soc 1997;45:482-488.
3. Kletsas D. Aging of fibroblasts. In: Kaul SC, Wadhwa R (eds). Aging of Cells In and Outside the Body. Kluwer Academic Publishers: Dordrecht, The Netherlands, 2003, pp 27-46.
4. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-9367.
5. Kurz DJ, Decary S, Hong Y, et al. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 2000;113(Part 20): 3613-3622.
6. Minamino T, Miyauchi H, Yoshida T, et al. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002;105:1541-1544.
7. Shelton DN, Chang E, Whittier PS, et al. Microarray analysis of replicative senescence. Curr Biol 1999;9:939-945.
8. Schnabl B, Purbeck CA, Choi YH, et al. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 2003;37:653-664.
9. Cotran RS, Mayadas-Norton T. Endothelial adhesion molecules in health and disease. Pathol Biol (Paris) 1998;46:164-170.
10. Poston RN, Haskard DO, Coucher JR, et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992;140:665-673.
11. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996;74:13-33.
12. Burne MJ, Elghandour A, Haq M J, et al. IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 up-regulation in ischemia reperfusion injury. J Leukoc Biol 2001;70:192-198.
13. Arnould T, Michiels C, Remacle J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol 1993;264:C1102-C1110.
14. Quarmby S, Kumar P, Kumar S. Radiation-induced normal tissue injury: role of adhesion molecules in leukocyte-endothelial cell interactions. Int J Cancer 1999;82:385-395.
15. Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 1999;66:876-888.
16. Takizawa K, Kamijo R, Ito D, et al. Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappa B independent pathway. Br J Cancer 1999;80:954-963.
17. Sun B, Fan H, Honda T, et al. Activation of NF-kappa B and expression of ICAM-1 in ischemic-reperfused canine myocardium. J Mol Cell Cardiol 2001;33:109-119.
18. Hallahan DE, Virudachalam S, Kuchibhotla J. Nuclear factor kappa B dominant negative genetic constructs inhibit X-ray induction of cell adhesion molecules in the vascular endothelium. Cancer Res 1998;58:5484-5488.
19. Gorgoulis VG, Zacharatos P, Kotsinas A, et al. p53 activates ICAM-1 (CD54) expression in an NF-κB-independent manner. EMBO J 2003;22:1567-1578.
20. Donehower LA. Does p53 affect organismal aging? J Cell Physiol 2002;192:23-33.
21. Tyner SD, Venkatachalam S, Choi J, et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002;415:45-53.
22. Saito H, Papaconstantinou J. Age-associated differences in cardiovascular inflammatory gene induction during endotoxic stress. J Biol Chem 2001;276:29307-29312.
23. Pratsinis H, Tsagarakis S, Zervolea I, et al. Chronic in vivo exposure to glucocorticoids prolongs cellular lifespan: the case of Cushing's syndrome-patients' fibroblasts. Exp Gerontol 2002;37:1237-1245.
24. Hsieh JK, Kletsas D, Clunn G, et al. p53, p21(WAF1/ CIP1), and MDM2 involvement in the proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000;20:973-981.
25. Pratsinis H, Demoliou-Mason C, Hughes A, et al. A novel in vitro model of conditionally immortalized human vascular smooth muscle cells. A tool for aging studies. Ann NY Acad Sci 2000;908:321-323.
26. Komarov PG, Komarova EA, Kondratov RV, et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999;285:1733-1737.
27. Pierce JW, Schoenleber R, Jesmok G, et al. Novel inhibitors of cytokine-induced Ikappa Balpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997;272:21096-21103.
28. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-1374.
29. Komarova EA, Gudkov AV. Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors. Biochem Pharmacol 2001;62:657-667.
30. Munro E, Chan P, Patel M, et al. Consistent responses of the human vascular smooth muscle cell in culture: implications for restenosis. J Vasc Surg 1994;20:482-487.
31. Schwartz SM, Murry CE. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med 1998;49:437-460.
32. Manfredi JJ, Prives C. The transforming activity of simian virus 40 large tumor antigen. Biochim Biophys Acta 1994;1198:65-83.
33. Ihling C, Haendeler J, Menzel G, et al. Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. J Pathol 1998;185:303-312.
34. Wright WE, Shay JW. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr Opin Genet Dev 2001;11:98-103.
35. Hornsby PJ. Cellular senescence and tissue aging in vivo. J Gerontol A Biol Sci Med Sci 2002;57: B251-B256.
36. Oshima J, Campisi J, Tannock TC, et al. Regulation of c-fos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors. J Cell Physiol 1995;162:277-283.
37. Lozano G, Elledge SJ. p53 sends nucleotides to repair DNA. Nature 2000;404:24-25.
38. Webley K, Bond JA, Jones CJ, et al. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol Cell Biol 2000;20:2803-2808.
39. Noda A, Ning Y, Venable SF, et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994;211:90-98.
40. Kirkwood TB, Austad SN. Why do we age? Nature 2000;408:233-238.
41. Campisi J. Between Scylla and Charybdis: p53 links tumor suppression and aging. Mech Ageing Dev 2002;123:567-573.
42. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
43. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1876-1890.
44. Guevara NV, Kim HS, Antonova EI, et al. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med 1999;5:335-339.
45. Ihling C, Menzel G, Wellens E, et al. Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol 1997;17:2218-2224.
46. Bennett MR, Macdonald K, Chan SW, et al. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res 1998;82:704-712.
47. Fenton M, Barker S, Kurz DJ, et al. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler Thromb Vasc Biol 2001;21:220-226.
48. Wick G, Berger P, Jansen-Durr P, et al. A Darwinian-evolutionary concept of age-related diseases. Exp Gerontol 2003;38:13-25.
49. Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 2002;34:1401-1414.